DalsnaFinance › Analyst accuracy › H.C. Wainwright › BIIB target
Biogen stock price target raised to $251 by H.C. Wainwright
H.C. Wainwright raised its price target on Biogen Inc. to $251 from $237 while maintaining a Buy rating
A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.